Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $164.00 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $108.35 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $20.59 | 1 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $18.33 | 1 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $16.73 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.74 | 2 | Veloxis Pharmaceuticals, Inc. ($23.41) |
| 2023 | $37.77 | 2 | Veloxis Pharmaceuticals, Inc. ($37.77) |
| 2022 | $67.76 | 4 | Veloxis Pharmaceuticals, Inc. ($47.17) |
| 2021 | $16.73 | 1 | Myriad Genetic Laboratories, Inc. ($16.73) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: TRANSPLANTATION | ||||||
| 10/17/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: TRANSPLANTATION | ||||||
| 05/10/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: TRANSPLANTATION | ||||||
| 12/13/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Immunosuppresant | ||||||
| 11/18/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Immunosuppresant | ||||||
| 10/19/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Immunosuppresant | ||||||
| 07/27/2022 | AstraZeneca Pharmaceuticals LP | EVUSHELD (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Vaccines & Immune Therapies | ||||||
| 01/27/2021 | Myriad Genetic Laboratories, Inc. | BRACAnalysis CDx (Device) | Food and Beverage | Cash or cash equivalent | $16.73 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 28 | 30 | $12,520 | $2,632 |
| 2022 | 3 | 67 | 73 | $29,205 | $5,771 |
| 2021 | 3 | 67 | 78 | $23,105 | $5,901 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 14 | $6,760 | $1,552 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 16 | $5,760 | $1,080 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 25 | $12,000 | $2,724 | 22.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 28 | 30 | $10,725 | $1,658 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 18 | $6,480 | $1,389 | 21.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 27 | 34 | $11,220 | $2,725 | 24.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 28 | 32 | $10,435 | $2,513 | 24.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 12 | 12 | $1,450 | $663.36 | 45.7% |
About Malissa Aponte, RN, FNP-C
Malissa Aponte, RN, FNP-C is a Registered Nurse healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2019. The National Provider Identifier (NPI) number assigned to this provider is 1750942884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Malissa Aponte, RN, FNP-C has received a total of $164.00 in payments from pharmaceutical and medical device companies, with $41.74 received in 2024. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($164.00).
As a Medicare-enrolled provider, Aponte has provided services to 162 Medicare beneficiaries, totaling 181 services with total Medicare billing of $14,304. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Stony Brook, NY
- Active Since 06/28/2019
- Last Updated 12/03/2019
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1750942884
Products in Payments
- ENVARSUS (Drug) $61.18
- Envarsus (Drug) $47.17
- EVUSHELD (Drug) $20.59
- Nubeqa (Drug) $18.33
- BRACAnalysis CDx (Device) $16.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Stony Brook
Ms. Susan Aiello, Np, NP
Registered Nurse — Payments: $1,987
Nancy Koh, Np-C, NP-C
Registered Nurse — Payments: $687.30
Mrs. Maricel Franzese, Fnp, FNP
Registered Nurse — Payments: $253.59
Ada Gutierrez, Np, NP
Registered Nurse — Payments: $161.28
Mr. Gary Yam
Registered Nurse — Payments: $154.45
Laura Montgomery, Np, NP
Registered Nurse — Payments: $143.62